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Abstract In mouse models, CCAAT enhancer-binding
protein beta (CEBPB) is necessary for M2 macrophage-
mediated regeneration after muscle injury. In humans,
CEBPB expression in blood was strongly associated with
muscle strength. In this study we aimed to test whether
CEBPB expression in blood in people is increased 2 days
after exercise designed to induce muscle damage and
subsequent repair. Sixteen healthy male volunteers
undertook elbow flexor exercises designed to induce
acute muscle micro-damage. Peripheral blood samples
were collected at baseline and days 1, 2, 4 and 7 fol-
lowing exercise. Expression of CEBPB and related genes
were analysed by qRT-PCR. Extent of muscle damage
was determined by decline in maximal voluntary iso-
metric torque and by plasma creatine kinase activity.
Nine subjects had peak (day 4) creatine kinase activity
exceeding 10,000 U/l. In this subgroup, CEBPB expres-
sion was elevated from baseline to 2 days post exercise
(paired-samples t(1,8) = 3.72, p = 0.006). Related
expression and selected cytokine changes after exercise
did not reach significance. Muscle-damaging exercise in
humans can be followed by induction of CEBPB tran-
script expression in peripheral blood. Associations
between CEBPB expression in blood and muscle strength
may be consistent with the CEBPB-dependent muscle
repair process.
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Introduction
After muscle injury or change of use, repair starts with an
initial acute inflammatory response (typically from 0 to
48 h) followed by a repair and regeneration phase, typi-
cally lasting from 48 h to 10 days [1]. CCAAT/enhancer-
binding protein-beta (C/EBP-b, encoded for by CEBPB
mRNA) is a pleiotropic transcription factor that regulates
several immune cell functions. C/EBP-b has been shown to
be central to post-injury muscle repair since CEBPB
expression is markedly increased during macrophage dif-
ferentiation towards an anti-inflammatory (M2) ‘repair’
phenotype that governs the integration of newly formed
myoblasts into regenerating muscle tissue [2].
In a murine model of repair after a muscle injury,
deletion of cAMP response element-binding protein
(CREB) binding sites in the C/EBP-b promoter (thereby
reducing CEBPB expression) in macrophages prevented
the transition to an M2 regrowth and repair phenotype and
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inhibited muscle regeneration, resulting in fibrosis and
muscle fibre loss, compromising muscle function [3].
Following injury, skeletal muscle undergoes a program
of regeneration. Satellite progenitor cells proliferate as
myoblasts and fuse into myotubes at the site of damage,
where they differentiate into fully regenerated muscle
fibres [4]. This sequence is mediated by a cascade of
myogenic regulatory factors, which are subject to signal-
ling from resident or infiltrating macrophages, and sys-
temic factors originating in T lymphocytes. The
proliferative phase of myoblasts is promoted by pro-
inflammatory (M1) macrophages. Subsequently, alterna-
tively activated M2 macrophages stimulate myotube dif-
ferentiation [5]. M2 signal induction is mediated by Th2
cytokines [6].
We have previously demonstrated that the expression of
the CEBPB gene in blood was the most strongly transcript
associated with grip strength in 698 mostly older people in
the InCHIANTI study in a transcriptome-wide analysis of
human circulating blood leukocytes [7]. A potential
mechanism explaining the strength-blood CEBPB associ-
ation may be the role of C/EBP-b in muscle regeneration
following lifelong muscle stress and injury [3]. Contrac-
tion-induced damage to muscle is common in everyday
life, especially during lengthening contractions, and
decreased repair after such damage has been linked to
muscle strength, particularly in old age [8].
In the current study, we aimed to establish whether
exercise-induced muscle damage (EIMD) in humans
results in increases in CEBPB expression in blood, con-
sistent with CEBPB’s role in post-injury muscle repair,
which typically shows sharply increasing numbers of M2
macrophages at the injury site by 48 h after injury [1]. We
also tested whether blood CEBPB and related expression
and plasma cytokines exhibit changes consistent with the
muscle regeneration program in human volunteers fol-
lowing EIMD. Here we present evidence that CEBPB
expression is altered with EIMD, and CEBPB expression is
associated with changes in markers characteristic of
inflammatory polarisation.
Methods
Sixteen healthy and physically active males [age, x
(±SD) = 43.1 (18.5) years] undertook three sets of
eccentric loading, 80 % 1RM [x (±SD) = 25.4 (5.1) kg,
each set to task failure, separated by 2 min recovery] of the
elbow flexors. Eccentric elbow flexion exercise is known to
induce structural damage in humans [9]. The exercise
protocol we used is consistent with inflammation in the
biceps brachii and brachialis muscles [10]; maximal vol-
untary contraction (MVC) was assessed at 60 of flexion to
allow potentially a greater contribution of damaged
brachialis muscle than at 90. MVC was assessed (peak
torque, 5 9 3 s isometric contractions/3 s rest) prior to
exercise and during recovery on an isokinetic dynamome-
ter (Biodex System 3, Biodex Medical Systems, NY,
USA). This project was approved by the ethics committee
of the Department of Sport and Health Sciences, University
of Exeter. Informed consent forms were signed by partic-
ipants. Exclusion criteria included hypertension, injury,
illness and medications related to inflammation.
Six millilitres of venous blood was collected into a
lithium heparin Vacutainer (Becton-Dickinson, USA) and
2.5 ml into a PAXGene blood tube (PreAnalytix GmbH,
Hombrechtikon, Switzerland) prior to and 1, 2, 4 and
7 days post exercise. These time points were chosen to
coincide with the M1/M2 phenotype muscle regeneration
model described by Tidball and Villalta [1]. The lithium
heparin tube was centrifuged for 10 min at 4,000 RPM; the
supernatant was harvested and analysed immediately for
creatine kinase (CK) activity. The PAXGene tubes were
inverted ten times, incubated at room temperature for
*3 h and stored without separation at -80 C.
Creatine kinase activity was measured at 37 C using
the colorimetric technique described by Szasz [11].
Absorbance was recorded at k 340 nm on a Jenway 6300
spectrophotometer (Bibby Scientific limited, Staffordshire,
UK) and enzymatic activity quantified using a linear
regression equation derived from a 2-point calibration of
known standards.
Th1 and Th2 cytokines were quantified in plasma by
electrochemiluminescence multiplex assay (Th1/Th2
10-plex, Meso Scale Discovery, Rockville, MD, USA). The
panel of cytokines measured IFN-c, IL-1b, IL-10, IL-12
p70, IL-13, IL-2, IL-4, IL-5, IL-8 and TNF-a.
For RNA extraction the PaxGene blood RNA kit
(QIAGEN Ltd., Crawley, UK) and QiaCube automated
system were used. mRNA was reverse transcripted to
complimentary DNA using Superscript VILO (Applied
Biosystems, USA) and amplified. cDNA was loaded onto
custom TaqMan low density array (TLDA) cards on the
ABI Prism 7900HT platform (Life Technologies, Carlsbad,
CA, USA). Genes included in the study were quantified
relative to an endogenous control gene (PPIA). Normali-
sation to PPIA precludes the need to correct for leucocy-
tosis and has been well validated for its use as an
appropriate housekeeping gene [12]. Samples were
amplified in triplicate over 55 cycles. The quantitative
value obtained from TaqMan real-time RT-PCR is a
threshold cycle (CT). The fold differences between time
conditions were calculated from the relativised CT values
(CT gene X-CT housekeeping gene, PPIA) according to the
comparative CT method. Genes quantified included seven
associated with the ‘classical’ inflammatory T1 phenotype
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and 7 (including CEBPB) with an ‘alternative’ anti-
inflammatory T2 phenotype (Table S1).
Within-group means were compared by paired t-tests for
differences at a priori time points relevant to expected
outcomes, in particular the rise from baseline to the mean
of the subsequent 2 days, during which time M2 polarisa-
tion is expected to be induced. Relationships between
mRNA expression and circulating cytokine concentrations
were explored by Pearson’s correlation coefficients. The
relationships between blood transcript expression changes
and markers of damage severity (loss of function and CK
activity) were assessed using robust regression analysis.
Statistical significance was accepted at p \ 0.05.
Results
Maximal voluntary contraction (MVC, 60 flexion)
decreased from baseline and remained significantly
depressed throughout the test period (pairwise repeated
measures comparisons p \ 0.05, Fig. 1a). Plasma CK
activity (U/l, at 37 C) increased from baseline (p \ 0.05)
with the greatest CK activity on day 4 (p \ 0.05, Fig. 1b),
although only 9 of the 16 subjects showed peak increases in
CK exceeding 10,000 U/l. Peak CK activity for each par-
ticipant was significantly associated with the maximum
decrease in MVC (Spearman’s rho = -0.618, p = 0.013).
Overall CEBPB gene expression change after exercise
(day 2, baseline) did not reach significance (p [ 0.05).
However in the subset whose peak CK activity exceeded
10,000 U/l, CEBPB expression did increase from baseline
to 2 days post exercise (t(1,8) = 3.72, p = 0.006, Fig. 1c,
d). The same change in CEBPB expression was observed in
a subset of ten subjects whose 24 h post exercise MVC
decreased [17 % (t(1,9) = 2.57, p = 0.03). The repeated
measures of CEBPB expression over the 7 days did not
significantly vary over time (ANOVA p [ 0.05); only the
day 2 change from baseline (in the high CK group) was
significant (ANOVA p = 0.014). Supplementary Table 4
contains the CEBPB expression data at each time point and
peak CK measure. There were no overall significant
changes post exercise in the selected plasma cytokine
concentration (Table S2) or other transcripts (Table S3),
and none of these were significant in the high CK
subgroup.
Supporting the concept that CEBPB changes are related
to T lymphocyte or macrophage differentiation, D CEBPB
expression correlated with D IL-1b (r2 = 0.701,
p = 4.14 9 10-5, Fig. 2a), ARG1 (r2 = 0.457, p = 0.004,
Fig. 2b) and STAT1 (r2 = 0.402, p = 0.008) expression.
We also observed positive correlations between DCEBPB
Fig. 1 Time-course and relationship with CEBPB expression. Iso-
metric strength (nm torque, ± SEM) decreases from baseline (a,
*p \ 0.05, n = 16) post-damage. Plasma creatine kinase activity (U/
l, at 37 C, ± SEM) increases from baseline (b, *p \ 0.05, n = 16),
peaking on day 4. Mean CEBPB blood transcript expression change
(CEBPB quantification refers to CEBPB transcript expression relative
to levels of the endogenous control gene PPIA and normalised to the
mean CEBPB level over all samples, ± SEM) is higher at day 2 in
n = 9 subjects with[10,000 peak plasma creatine kinase activity (c,
*p = 0.006). d Shows the participants’ change in CEBPB expression
(day 2 minus baseline) and peak CK levels
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and Dplasma INF-c (r2 = 0.369, p = 0.013, Fig. 2c) and
IL4 concentration change (r2 = 0.29, p = 0.031, Fig. 2c).
D = [day 1 ? day 2]/2 - baseline. After negative changes
in CEBPB expression had been excluded from the analysis,
all the above associations remained significant except for
interleukin 4.
Discussion
In our previous ageing study, we showed that CEBPB
expression in circulating leukocytes correlated with muscle
strength in older people [7]. We hypothesised that this
relationship may reflect the reported critical role CEBPB
plays in leukocyte mediation of muscle regeneration fol-
lowing injury. We anticipated that a single bout of exer-
cise-induced muscle damage would initiate a leukocyte-
governed muscle regeneration response in which CEBPB
expression would provide the essential switch between M1
and M2 inflammatory phenotypes. Thus, in a microcosm,
we intended to create a model to assess the relevance of
chronic circulating CEBPB expression that in future
research could be applied to the study of age-related
functional impairment. Here we present evidence that
muscle-damaging exercise resulted in elevated blood CE-
BPB expression in volunteers exhibiting symptoms of more
severe damage (elevated CK activity and decreased MVC).
Although the degree of muscle damage was necessarily
very small compared to the significant injuries explored in
laboratory models, we found gene expression with similar
direction and timing to those seen in models of the Th1/
Th2 transition [1]. We also found suggestive evidence that
CEBPB expression changes post exercise correlated with
changes in Th1- and Th2-linked cytokine and transcript
levels as hypothesised. These findings imply that in the
exercise-induced muscle damage model, systemic inflam-
matory status may play a remote role in the governance of
muscle remodelling, although more work is needed on this
to provide definitive results.
Since we measured gene transcripts expressed in blood
leukocytes, rather than in leukocytes resident in damaged
muscle, we were challenged to justify our reasoning behind
linking CEBPB expression to muscle remodelling. Much of
the research into immunomodulatory effects on muscle
regeneration has focused on the actions of resident mac-





























































































Fig. 2 Associations of CEBPB expression to macrophage polarisa-
tion-associated markers. Following exercise-induced muscle damage,
CEBPB blood transcript expression change shows positive correla-
tions with IL1b (a, p = 4.14 9 10-5) and ARG1 (b, p = 0.004) blood
transcript expression change as well as change in circulating INF-c (c,
p = 0.013) and IL-4 concentration in plasma (d, p = 0.031)
(DT = [day 1 ? day 2]/2 - baseline, n = 16)
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occur in situ in damaged muscle [5] rather than prior to
extravasation, and whether activated macrophages re-enter
the circulation is unclear. Yet there may be a role of sys-
temic T lymphocytes by either influencing myogenesis
directly or remote macrophage phenotype induction [1].
Indeed, CEBPB is involved in the differentiation of TH0–
TH1 and TH2 CD4?cells [13], and the molecular cascade
that determines the inflammatory phenotype shares simi-
larities with that of the macrophage. The relationships
between CEBPB and Th1/Th2 markers may support this.
Circulating IL4 may originate from regenerating muscle
[14], known to stimulate CEBPB expression involved in
M2 macrophage polarity. CEBPB expression is also influ-
enced by IL1b [15], suggesting activation from pro-
inflammatory leukocytes. We also report a relationship
between CEBPB and ARG1 expression change; M2 mac-
rophages produce arginase 1, which competes with iNOS
for L-arginine [6], thereby decreasing the M1 control of
myogenic events [16]. In IL4-stimulated macrophages,
ARG-1 expression is dependent on C/EBP-b-mediated
transcription [17]. These relationships provide some sup-
port that circulating CEBPB expression is related to Th1/
Th2 inflammatory polarity. A role for peripheral factors in
age-related muscle regeneration is supported by a murine
study that infused serum from young mice into old,
boosting the regeneration capacity [18].
Chronic low-grade systemic inflammation is well known
to be related to decreases in muscle mass and functional
capacity in longitudinal studies of aging [19–21]. Evidence
of an anti-inflammatory antagonistic effect is sparse,
although IL-10 is emerging as a key mediator of macro-
phage inflammatory status, associated with muscle regen-
eration [22]. As a transcription factor, CEBPB responds to
environmental cues and elevates the production of IL-10,
thus acting as an upstream mediator of the anti-inflamma-
tory cascade, potentially ameliorating the negative conse-
quences of inflammation. Induction of pro-inflammatory
mediators of myoblast proliferation is essential for optimal
muscle regeneration [23]; thus CEBPB may possibly be a
target for pharmaceutical therapy to facilitate endogenous
anti-inflammatory responses.
This study has several limitations, perhaps most
importantly the relatively small sample size of 16, limiting
statistical power. This small sample size likely explains
why we did not detect an association between baseline
muscle strength and baseline CEBPB expression, as pre-
viously reported in our analysis in 698 subjects [7]. The
observed changes in MVC and CK suggest that structural
damage and inflammation occurred in all volunteers,
although evidence of inflammatory polarity in circulation
was only observed in the most severely damaged individ-
uals. The varying severity of damage and resulting disas-
sociation from a universal inflammatory time course
weakened potential main effects. Statistical power may be
improved in future with the recruitment of a larger sample
size or by employing laboratory techniques to improve the
resolution of data. Creatine kinase is a widely used but
imperfect measure of muscle injury, and follow-up studies
could be strengthened by direct measures of injury, mac-
rophage infiltration and repair. Changes in CEBPB
expression from baseline to day 2 were variable between
study subjects: in the group (n = 9) with CK changes
above 10,000 U/l one individual showed essentially no
change in CEBPB expression from baseline. Decreases in
expression of CEBPB did occur in those with lower peak
CK values and are likely to reflect the low baseline
expression of this gene, against which small fluctuations in
RT-PCR results appear to cause larger relative changes (a
low signal-to-noise ratio).
We did not account for changes in leukocyte counts and
subsets, but instead observed Th1/Th2 activity via circu-
latory factors and normalised rather than quantified gene
expression. Measures of the abundance of specific cell
subtypes (especially monocytes and macrophages) and
gene expression within these cells could have provided
more direct evidence linking CEBPB expression and
macrophage activation. Future work might explore CEBPB
and related expression after both a first and repeat bouts of
exercise, as the latter should attenuate damage. We used t-
tests in this analysis focussed, for example, on the change
in CEBPB expression from baseline to day 2 rather than
modelling the whole sequence of expression changes
across all measures using a repeated measures ANOVA
approach. This is because we expected a pattern of early
increase in CEBPB expression by day 2 with a subsequent
decline thereafter, given the dynamics of immune changes
after muscle injury as summarised by Tidball and Villalta
[1] and others. ANOVA tests of baseline and day 2 CEBPB
expression gave similar results to t-tests, but repeat mea-
sures ANOVA for all CEBPB measures was not significant.
In conclusion, CEBPB expression in blood was previously
reported to be associated with muscle strength in humans
and a suggested mechanism for this is that CEBPB
expression in macrophages is necessary for repair after
muscle injury. We therefore sought to test whether CEBPB
expression in blood leukocytes is responsive to muscle
injury inducing exercise. We have shown that in volunteers
who likely sustained more severe muscle injury (i.e. those
with CK levels [10,000 U/l) the expected increase in
CEBPB expression in blood was present 48 h after exer-
cise. Further study is needed to confirm the cellular origin
of the CEBPB and related expression changes and to
confirm the mechanistic relationship with downstream
muscular regeneration events.
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